92 related articles for article (PubMed ID: 8020267)
1. Association of increased prostaglandin E2 content in bronchoalveolar lavage fluid and intrathoracic malignancy.
Funahashi A; Harland RW; LeFever A
Chest; 1994 Jul; 106(1):166-72. PubMed ID: 8020267
[TBL] [Abstract][Full Text] [Related]
2. Elevated prostaglandin E2 levels in bronchoalveolar lavage fluid of patients with bronchogenic carcinoma.
LeFever A; Funahashi A
Chest; 1990 Dec; 98(6):1397-402. PubMed ID: 2173996
[TBL] [Abstract][Full Text] [Related]
3. Vascular Endothelial Growth Factor-D (VEGF-D) is Elevated in Bronchoalveolar Lavage Fluid of Patients with Lung Squamous Carcinoma.
Lv D; Tan L; Zhang Q; Ma H; Zhang Y; Zhang Q; Yu Y; Chen Z; Ding Q; Deng Z
Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775896
[TBL] [Abstract][Full Text] [Related]
4. Inhaled glutathione decreases PGE2 and increases lymphocytes in cystic fibrosis lungs.
Hartl D; Starosta V; Maier K; Beck-Speier I; Rebhan C; Becker BF; Latzin P; Fischer R; Ratjen F; Huber RM; Rietschel E; Krauss-Etschmann S; Griese M
Free Radic Biol Med; 2005 Aug; 39(4):463-72. PubMed ID: 16043018
[TBL] [Abstract][Full Text] [Related]
5. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
6. A comparative study on ferritin concentration in serum and bilateral bronchoalveolar lavage fluid of patients with peripheral lung cancer versus control subjects.
Fracchia A; Ubbiali A; El Bitar O; Pacetti M; Sommariva E; Arreghini M; Longhini E; Bonalumi GP
Oncology; 1999 Apr; 56(3):181-8. PubMed ID: 10202271
[TBL] [Abstract][Full Text] [Related]
7. PGE2 and PGF2 alpha content in bronchoalveolar lavage fluid obtained from patients with eosinophilic pneumonia.
Ogushi F; Ozaki T; Kawano T; Yasuoka S
Chest; 1987 Feb; 91(2):204-6. PubMed ID: 3467919
[TBL] [Abstract][Full Text] [Related]
8. Discovery of potential protein biomarkers of lung adenocarcinoma in bronchoalveolar lavage fluid by SWATH MS data-independent acquisition and targeted data extraction.
Ortea I; Rodríguez-Ariza A; Chicano-Gálvez E; Arenas Vacas MS; Jurado Gámez B
J Proteomics; 2016 Apr; 138():106-14. PubMed ID: 26917472
[TBL] [Abstract][Full Text] [Related]
9. [Change of prostaglandin E2 and interleukin-12, interleukin-13 in the bronchoalveolar lavage fluid and the serum of the patients with idiopathic pulmonary fibrosis].
Li JZ; Li ZH; Kang J; Hou XM; Yu RJ
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jun; 27(6):378-80. PubMed ID: 15256084
[TBL] [Abstract][Full Text] [Related]
10. B Cell-Attracting Chemokine-1 and Progranulin in Bronchoalveolar Lavage Fluid of Patients with Advanced Non-small Cell Lung Cancer: New Prognostic Factors.
Naumnik W; Panek B; Ossolińska M; Naumnik B
Adv Exp Med Biol; 2019; 1150():11-16. PubMed ID: 30357709
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of diagnostic value of four tumor markers in bronchoalveolar lavage fluid of peripheral lung cancer.
Li J; Chen P; Mao CM; Tang XP; Zhu LR
Asia Pac J Clin Oncol; 2014 Jun; 10(2):141-8. PubMed ID: 23551358
[TBL] [Abstract][Full Text] [Related]
12. Increased level of annexin A1 in bronchoalveolar lavage fluid as a potential diagnostic indicator for lung cancer.
Biaoxue R; Xiguang C; Hua L; Tian F; Wenlong G
Int J Biol Markers; 2017 Mar; 32(1):e132-e140. PubMed ID: 28009433
[TBL] [Abstract][Full Text] [Related]
13. Role of prostaglandin E
Okazaki A; Hara J; Ohkura N; Fujimura M; Sakai T; Abo M; Katayama N; Kasahara K; Nakao S
Pulm Pharmacol Ther; 2018 Feb; 48():62-70. PubMed ID: 28951192
[TBL] [Abstract][Full Text] [Related]
14. Effect of prostaglandin E2-producing nonmetastatic Lewis lung carcinoma cells on the migration of prostaglandin E2-responsive metastatic Lewis lung carcinoma cells.
Young MR; Young ME; Wepsic HT
Cancer Res; 1987 Jul; 47(14):3679-83. PubMed ID: 3109729
[TBL] [Abstract][Full Text] [Related]
15. Association of a functional prostaglandin E2-protein kinase A coupling with responsiveness of metastatic Lewis lung carcinoma variants to prostaglandin E2 and to prostaglandin E2-producing nonmetastatic Lewis lung carcinoma variants.
Young MR; Duffie GP; Lozano Y; Young ME; Wright MA
Cancer Res; 1990 May; 50(10):2973-8. PubMed ID: 2159367
[TBL] [Abstract][Full Text] [Related]
16. Bronchoalveolar lavage fluid alteration in antioxidant and inflammatory status in lung cancer patients.
Kontakiotis T; Katsoulis K; Hagizisi O; Kougioulis M; Gerou S; Papakosta D
Eur J Intern Med; 2011 Oct; 22(5):522-6. PubMed ID: 21925065
[TBL] [Abstract][Full Text] [Related]
17. Fibronectin in bronchoalveolar lavage fluid in lung cancer: tumor or inflammatory marker?
Cremades MJ; Menéndez R; Rubio V; Sanchis J
Respiration; 1998; 65(3):178-82. PubMed ID: 9670297
[TBL] [Abstract][Full Text] [Related]
18. Adenosine deaminase activity and lysozyme levels in bronchoalveolar lavage fluid in patients with pulmonary tuberculosis.
Orphanidou D; Stratakos G; Rasidakis A; Toumbis M; Samara J; Bakakos P; Jordanoglou J
Int J Tuberc Lung Dis; 1998 Feb; 2(2):147-52. PubMed ID: 9562125
[TBL] [Abstract][Full Text] [Related]
19. Celecoxib modulates the capacity for prostaglandin E2 and interleukin-10 production in alveolar macrophages from active smokers.
Mao JT; Roth MD; Serio KJ; Baratelli F; Zhu L; Holmes EC; Strieter RM; Dubinett SM
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5835-41. PubMed ID: 14676104
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Osteoprotegerin and sRANKL in Bronchoalveolar Lavage Fluid of Patients with Advanced Non-small Cell Lung Cancer.
Naumnik W; Płońska I; Ossolińska M; Nikliński J; Naumnik B
Adv Exp Med Biol; 2018; 1047():1-6. PubMed ID: 29052177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
